| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.02e-05 | 188 | 21 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | structural molecule activity | 2.37e-04 | 891 | 21 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | integrin binding | 7.84e-04 | 175 | 21 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | protease binding | 8.64e-04 | 181 | 21 | 3 | GO:0002020 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 2.17e-03 | 66 | 21 | 2 | GO:0005080 | |
| GeneOntologyMolecularFunction | coreceptor activity | 2.58e-03 | 72 | 21 | 2 | GO:0015026 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 2.65e-03 | 73 | 21 | 2 | GO:0050840 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 3.67e-05 | 410 | 20 | 5 | GO:0031589 | |
| GeneOntologyCellularComponent | keratin filament | KRTAP16-1 KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 1.91e-16 | 97 | 21 | 9 | GO:0045095 |
| GeneOntologyCellularComponent | intermediate filament | KRTAP16-1 KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 4.70e-13 | 227 | 21 | 9 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRTAP16-1 KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 1.77e-12 | 263 | 21 | 9 | GO:0045111 |
| GeneOntologyCellularComponent | supramolecular fiber | KRTAP16-1 AKAP13 KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 COL1A1 | 3.67e-09 | 1179 | 21 | 11 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRTAP16-1 AKAP13 KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 COL1A1 | 3.94e-09 | 1187 | 21 | 11 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRTAP16-1 AKAP13 KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 4.72e-09 | 899 | 21 | 10 | GO:0099513 |
| GeneOntologyCellularComponent | extracellular matrix | 4.02e-04 | 656 | 21 | 5 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 4.07e-04 | 658 | 21 | 5 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.73e-03 | 530 | 21 | 4 | GO:0062023 | |
| GeneOntologyCellularComponent | platelet alpha granule | 3.89e-03 | 93 | 21 | 2 | GO:0031091 | |
| GeneOntologyCellularComponent | neuromuscular junction | 5.59e-03 | 112 | 21 | 2 | GO:0031594 | |
| HumanPheno | Prolonged bleeding time | 1.74e-05 | 50 | 6 | 3 | HP:0003010 | |
| HumanPheno | Abnormality of skull ossification | 1.17e-04 | 94 | 6 | 3 | HP:0002703 | |
| HumanPheno | Prolonged bleeding after surgery | 1.56e-04 | 17 | 6 | 2 | HP:0004846 | |
| HumanPheno | Decreased calvarial ossification | 1.56e-04 | 17 | 6 | 2 | HP:0005474 | |
| HumanPheno | Abnormality of von Willebrand factor | 2.64e-04 | 22 | 6 | 2 | HP:0012146 | |
| HumanPheno | Prolonged bleeding after dental extraction | 2.89e-04 | 23 | 6 | 2 | HP:0006298 | |
| MousePheno | thick neurocranium | 1.03e-05 | 8 | 9 | 2 | MP:0030278 | |
| MousePheno | syndactyly | 2.33e-05 | 93 | 9 | 3 | MP:0000564 | |
| MousePheno | abnormal trabecular bone thickness | 2.72e-05 | 98 | 9 | 3 | MP:0009345 | |
| MousePheno | abnormal extracellular matrix morphology | 2.89e-05 | 100 | 9 | 3 | MP:0013258 | |
| MousePheno | abnormal tooth development | 3.64e-05 | 108 | 9 | 3 | MP:0000116 | |
| MousePheno | abnormal osteocyte morphology | 3.85e-05 | 15 | 9 | 2 | MP:0008753 | |
| MousePheno | abnormal compact bone thickness | 5.24e-05 | 122 | 9 | 3 | MP:0000134 | |
| MousePheno | abnormal osteocyte lacunocanalicular system morphology | 5.61e-05 | 18 | 9 | 2 | MP:0030485 | |
| MousePheno | reduced fertility | 8.15e-05 | 844 | 9 | 5 | MP:0001921 | |
| MousePheno | abnormal craniofacial development | 9.40e-05 | 425 | 9 | 4 | MP:0003935 | |
| MousePheno | decreased bone trabecular spacing | 1.01e-04 | 24 | 9 | 2 | MP:0013631 | |
| MousePheno | abnormal compact bone morphology | 1.46e-04 | 172 | 9 | 3 | MP:0003797 | |
| MousePheno | decreased susceptibility to induced thrombosis | 1.59e-04 | 30 | 9 | 2 | MP:0031120 | |
| MousePheno | oligodactyly | 2.70e-04 | 39 | 9 | 2 | MP:0000565 | |
| MousePheno | abnormal chest morphology | 2.70e-04 | 39 | 9 | 2 | MP:0004134 | |
| MousePheno | impaired branching involved in ureteric bud morphogenesis | 2.98e-04 | 41 | 9 | 2 | MP:0004936 | |
| MousePheno | increased compact bone thickness | 2.98e-04 | 41 | 9 | 2 | MP:0004148 | |
| MousePheno | decreased cardiac muscle contractility | 3.13e-04 | 223 | 9 | 3 | MP:0005140 | |
| MousePheno | increased trabecular bone thickness | 3.28e-04 | 43 | 9 | 2 | MP:0009347 | |
| MousePheno | abnormal branching involved in ureteric bud morphogenesis | 3.60e-04 | 45 | 9 | 2 | MP:0010981 | |
| MousePheno | abnormal response to injury | 3.72e-04 | 607 | 9 | 4 | MP:0005164 | |
| MousePheno | abnormal bone trabecular spacing | 4.09e-04 | 48 | 9 | 2 | MP:0013629 | |
| MousePheno | absent kidney | 4.99e-04 | 53 | 9 | 2 | MP:0000520 | |
| MousePheno | abnormal susceptibility to induced thrombosis | 4.99e-04 | 53 | 9 | 2 | MP:0020408 | |
| MousePheno | renal interstitial fibrosis | 5.18e-04 | 54 | 9 | 2 | MP:0003215 | |
| MousePheno | abnormal hair follicle development | 5.18e-04 | 54 | 9 | 2 | MP:0003704 | |
| MousePheno | abnormal neurocranium morphology | 5.43e-04 | 269 | 9 | 3 | MP:0000074 | |
| MousePheno | abnormal ureteric bud morphology | 5.77e-04 | 57 | 9 | 2 | MP:0006032 | |
| MousePheno | abnormal trabecular bone morphology | 6.70e-04 | 289 | 9 | 3 | MP:0000130 | |
| MousePheno | abnormal tooth hard tissue morphology | 7.05e-04 | 63 | 9 | 2 | MP:0003930 | |
| MousePheno | impaired muscle contractility | 7.25e-04 | 297 | 9 | 3 | MP:0000738 | |
| MousePheno | abnormal cardiac muscle contractility | 7.61e-04 | 302 | 9 | 3 | MP:0002972 | |
| MousePheno | decreased heart left ventricle muscle contractility | 7.74e-04 | 66 | 9 | 2 | MP:0031633 | |
| MousePheno | abnormal kidney interstitium morphology | 7.97e-04 | 67 | 9 | 2 | MP:0011425 | |
| MousePheno | abnormal tooth morphology | 8.85e-04 | 318 | 9 | 3 | MP:0002100 | |
| MousePheno | abnormal dental arch morphology | 8.93e-04 | 319 | 9 | 3 | MP:0030254 | |
| MousePheno | abnormal digit morphology | 9.26e-04 | 323 | 9 | 3 | MP:0002110 | |
| MousePheno | abnormal osteoclast physiology | 9.46e-04 | 73 | 9 | 2 | MP:0001541 | |
| MousePheno | abnormal bone strength | 9.72e-04 | 74 | 9 | 2 | MP:0001542 | |
| MousePheno | renal fibrosis | 1.08e-03 | 78 | 9 | 2 | MP:0003985 | |
| MousePheno | abnormal platelet activation | 1.37e-03 | 88 | 9 | 2 | MP:0006298 | |
| MousePheno | abnormal ureter morphology | 1.43e-03 | 90 | 9 | 2 | MP:0000534 | |
| MousePheno | increased bleeding time | 1.46e-03 | 91 | 9 | 2 | MP:0005606 | |
| MousePheno | abnormal kidney development | 1.53e-03 | 93 | 9 | 2 | MP:0000527 | |
| MousePheno | internal hemorrhage | 1.56e-03 | 387 | 9 | 3 | MP:0001634 | |
| MousePheno | abnormal autopod morphology | 1.60e-03 | 390 | 9 | 3 | MP:0000572 | |
| MousePheno | abnormal tail morphology | 1.76e-03 | 403 | 9 | 3 | MP:0002111 | |
| MousePheno | enlarged heart | 1.77e-03 | 916 | 9 | 4 | MP:0000274 | |
| MousePheno | abnormal muscle contractility | 1.95e-03 | 418 | 9 | 3 | MP:0005620 | |
| MousePheno | abnormal thrombosis | 1.98e-03 | 106 | 9 | 2 | MP:0005048 | |
| MousePheno | decreased heart ventricle muscle contractility | 2.02e-03 | 107 | 9 | 2 | MP:0005598 | |
| MousePheno | abnormal response of heart to induced stress | 2.09e-03 | 109 | 9 | 2 | MP:0004484 | |
| MousePheno | abnormal platelet physiology | 2.13e-03 | 110 | 9 | 2 | MP:0005464 | |
| MousePheno | abnormal urinary system development | 2.17e-03 | 111 | 9 | 2 | MP:0003942 | |
| MousePheno | abnormal trabecular bone volume | 2.25e-03 | 113 | 9 | 2 | MP:0010877 | |
| MousePheno | small lung | 2.33e-03 | 115 | 9 | 2 | MP:0003641 | |
| MousePheno | abnormal outer ear morphology | 2.49e-03 | 119 | 9 | 2 | MP:0002177 | |
| MousePheno | abnormal ear morphology | 2.73e-03 | 470 | 9 | 3 | MP:0002102 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 3.05e-03 | 489 | 9 | 3 | MP:0010630 | |
| MousePheno | abnormal bone trabecula morphology | 3.14e-03 | 134 | 9 | 2 | MP:0010867 | |
| MousePheno | abnormal osteoblast morphology | 3.28e-03 | 137 | 9 | 2 | MP:0004986 | |
| MousePheno | abnormal stationary movement | 3.77e-03 | 147 | 9 | 2 | MP:0001388 | |
| MousePheno | abnormal hair follicle morphology | 3.82e-03 | 148 | 9 | 2 | MP:0000377 | |
| MousePheno | abnormal jaw morphology | 3.84e-03 | 530 | 9 | 3 | MP:0000454 | |
| Domain | KAP | KRTAP16-1 KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 4.00e-18 | 58 | 21 | 9 | IPR002494 |
| Domain | Keratin_B2_2 | KRTAP16-1 KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-7 KRTAP10-6 KRTAP10-12 | 1.11e-14 | 39 | 21 | 7 | PF13885 |
| Domain | Keratin_B2 | KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 1.35e-14 | 40 | 21 | 7 | PF01500 |
| Domain | VWF_dom | 8.91e-10 | 42 | 21 | 5 | IPR001007 | |
| Domain | VWC_out | 4.53e-09 | 19 | 21 | 4 | SM00215 | |
| Domain | VWC | 2.38e-08 | 28 | 21 | 4 | PF00093 | |
| Domain | VWFC_1 | 6.80e-08 | 36 | 21 | 4 | PS01208 | |
| Domain | VWC | 8.50e-08 | 38 | 21 | 4 | SM00214 | |
| Domain | VWFC_2 | 8.50e-08 | 38 | 21 | 4 | PS50184 | |
| Domain | C8 | 3.48e-07 | 13 | 21 | 3 | SM00832 | |
| Domain | Unchr_dom_Cys-rich | 3.48e-07 | 13 | 21 | 3 | IPR014853 | |
| Domain | TIL_dom | 4.42e-07 | 14 | 21 | 3 | IPR002919 | |
| Domain | VWFD | 6.80e-07 | 16 | 21 | 3 | PS51233 | |
| Domain | VWD | 6.80e-07 | 16 | 21 | 3 | SM00216 | |
| Domain | VWF_type-D | 6.80e-07 | 16 | 21 | 3 | IPR001846 | |
| Domain | VWD | 6.80e-07 | 16 | 21 | 3 | PF00094 | |
| Domain | TIL | 7.89e-05 | 12 | 21 | 2 | PF01826 | |
| Domain | C8 | 7.89e-05 | 12 | 21 | 2 | PF08742 | |
| Domain | EGF-like_dom | 1.54e-04 | 249 | 21 | 4 | IPR000742 | |
| Domain | EGF_1 | 1.69e-04 | 255 | 21 | 4 | PS00022 | |
| Domain | EGF-like_CS | 1.85e-04 | 261 | 21 | 4 | IPR013032 | |
| Domain | EGF_2 | 1.96e-04 | 265 | 21 | 4 | PS01186 | |
| Domain | CT | 2.74e-04 | 22 | 21 | 2 | SM00041 | |
| Domain | Cys_knot_C | 3.56e-04 | 25 | 21 | 2 | IPR006207 | |
| Domain | CTCK_2 | 3.56e-04 | 25 | 21 | 2 | PS01225 | |
| Domain | Growth_fac_rcpt_ | 6.81e-04 | 156 | 21 | 3 | IPR009030 | |
| Domain | Laminin_G_2 | 9.15e-04 | 40 | 21 | 2 | PF02210 | |
| Domain | LamG | 1.11e-03 | 44 | 21 | 2 | SM00282 | |
| Domain | Laminin_G | 1.92e-03 | 58 | 21 | 2 | IPR001791 | |
| Domain | EGF_extracell | 2.05e-03 | 60 | 21 | 2 | IPR013111 | |
| Domain | EGF_2 | 2.05e-03 | 60 | 21 | 2 | PF07974 | |
| Domain | EGF | 2.21e-03 | 235 | 21 | 3 | SM00181 | |
| Domain | EGF_3 | 2.21e-03 | 235 | 21 | 3 | PS50026 | |
| Domain | - | 3.10e-03 | 74 | 21 | 2 | 3.40.50.410 | |
| Domain | VWFA | 3.79e-03 | 82 | 21 | 2 | PS50234 | |
| Domain | VWA | 3.97e-03 | 84 | 21 | 2 | SM00327 | |
| Domain | EGF_CA | 4.16e-03 | 86 | 21 | 2 | PF07645 | |
| Domain | - | 5.05e-03 | 95 | 21 | 2 | 2.60.120.200 | |
| Domain | EGF_Ca-bd_CS | 5.26e-03 | 97 | 21 | 2 | IPR018097 | |
| Domain | VWF_A | 5.47e-03 | 99 | 21 | 2 | IPR002035 | |
| Domain | EGF_CA | 5.47e-03 | 99 | 21 | 2 | PS01187 | |
| Domain | ASX_HYDROXYL | 5.58e-03 | 100 | 21 | 2 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.25e-03 | 106 | 21 | 2 | IPR000152 | |
| Domain | EGF_CA | 8.19e-03 | 122 | 21 | 2 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 8.45e-03 | 124 | 21 | 2 | IPR001881 | |
| Domain | EGF | 8.72e-03 | 126 | 21 | 2 | PF00008 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP16-1 KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 8.98e-13 | 217 | 17 | 9 | M27640 |
| Pathway | REACTOME_KERATINIZATION | KRTAP16-1 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 3.58e-12 | 153 | 17 | 8 | MM15343 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP16-1 ITGB3 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 1.62e-09 | 502 | 17 | 9 | MM14537 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP16-1 ITGB3 KRTAP10-9 NELL2 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 7.95e-08 | 1432 | 17 | 11 | M509 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.76e-06 | 76 | 17 | 4 | M27219 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.63e-06 | 84 | 17 | 4 | M7098 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 1.20e-05 | 38 | 17 | 3 | MM15456 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 1.30e-05 | 39 | 17 | 3 | M10735 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.12e-05 | 300 | 17 | 5 | M610 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 2.86e-05 | 7 | 17 | 2 | M48265 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 3.82e-05 | 8 | 17 | 2 | M48236 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.54e-05 | 59 | 17 | 3 | M27218 | |
| Pathway | WP_VITAMIN_D_RECEPTOR_PATHWAY | 5.98e-05 | 185 | 17 | 4 | M39718 | |
| Pathway | WP_FOCAL_ADHESION | 6.23e-05 | 187 | 17 | 4 | MM15913 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.94e-05 | 199 | 17 | 4 | M7253 | |
| Pathway | WP_FOCAL_ADHESION | 7.94e-05 | 199 | 17 | 4 | M39402 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 8.97e-05 | 12 | 17 | 2 | MM15093 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 8.97e-05 | 12 | 17 | 2 | MM15452 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 8.97e-05 | 12 | 17 | 2 | M27352 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 9.70e-05 | 76 | 17 | 3 | MM14867 | |
| Pathway | WP_OSTEOBLAST_SIGNALING | 1.24e-04 | 14 | 17 | 2 | M39599 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.35e-04 | 85 | 17 | 3 | M16441 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.42e-04 | 15 | 17 | 2 | M12101 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.42e-04 | 15 | 17 | 2 | M1262 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.42e-04 | 15 | 17 | 2 | MM14959 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.42e-04 | 15 | 17 | 2 | MM14961 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.63e-04 | 16 | 17 | 2 | M9450 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 2.31e-04 | 19 | 17 | 2 | M48230 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 3.94e-04 | 302 | 17 | 4 | M39719 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 4.72e-04 | 27 | 17 | 2 | M27217 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 4.72e-04 | 27 | 17 | 2 | M760 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 5.08e-04 | 28 | 17 | 2 | MM14958 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 5.27e-04 | 326 | 17 | 4 | MM15917 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.84e-04 | 30 | 17 | 2 | M27772 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 5.84e-04 | 30 | 17 | 2 | MM15812 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 5.84e-04 | 30 | 17 | 2 | M39641 | |
| Pathway | WP_PI3KAKT_SIGNALING | 6.10e-04 | 339 | 17 | 4 | M39736 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.65e-04 | 32 | 17 | 2 | MM14924 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 9.88e-04 | 39 | 17 | 2 | MM15272 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 1.04e-03 | 40 | 17 | 2 | M27557 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.09e-03 | 41 | 17 | 2 | M27778 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.20e-03 | 43 | 17 | 2 | M53 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 1.31e-03 | 45 | 17 | 2 | M27623 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.37e-03 | 46 | 17 | 2 | M198 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.43e-03 | 47 | 17 | 2 | MM14925 | |
| Pathway | PID_IL4_2PATHWAY | 2.64e-03 | 64 | 17 | 2 | M28 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 2.72e-03 | 65 | 17 | 2 | M38994 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.81e-03 | 66 | 17 | 2 | M18 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.33e-03 | 72 | 17 | 2 | M39403 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 3.37e-03 | 257 | 17 | 3 | MM15454 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.41e-03 | 258 | 17 | 3 | MM14572 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.42e-03 | 73 | 17 | 2 | MM15906 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 3.51e-03 | 74 | 17 | 2 | M160 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 3.52e-03 | 261 | 17 | 3 | M1077 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.99e-03 | 79 | 17 | 2 | M27643 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 4.30e-03 | 82 | 17 | 2 | M27626 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 5.84e-03 | 96 | 17 | 2 | M39581 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 1.05e-02 | 130 | 17 | 2 | MM15455 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 1.08e-02 | 132 | 17 | 2 | M724 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.21e-02 | 140 | 17 | 2 | M587 | |
| Pubmed | KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 4.92e-23 | 16 | 21 | 8 | 15028290 | |
| Pubmed | 1.02e-17 | 11 | 21 | 6 | 14962103 | ||
| Pubmed | KRTAP16-1 KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 1.61e-14 | 258 | 21 | 9 | 10830953 | |
| Pubmed | 3.12e-11 | 40 | 21 | 5 | 12359730 | ||
| Pubmed | 7.59e-10 | 4 | 21 | 3 | 33576766 | ||
| Pubmed | A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11. | 4.16e-08 | 12 | 21 | 3 | 8986815 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 22134168 | ||
| Pubmed | Beta3 integrin haplotype influences gene regulation and plasma von Willebrand factor activity. | 3.47e-07 | 2 | 21 | 2 | 18045606 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 19765213 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 7505120 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 17996853 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 12691260 | ||
| Pubmed | Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor. | 1.04e-06 | 3 | 21 | 2 | 30305279 | |
| Pubmed | Isolation and characterization of a collagen binding domain in human von Willebrand factor. | 1.04e-06 | 3 | 21 | 2 | 3490481 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 24840544 | ||
| Pubmed | Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. | 1.04e-06 | 3 | 21 | 2 | 3872140 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 32998468 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 18927433 | ||
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | KRTAP10-9 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-5 | 1.48e-06 | 630 | 21 | 6 | 36949045 |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 18487513 | ||
| Pubmed | Intercellular calcium communication regulates platelet aggregation and thrombus growth. | 2.08e-06 | 4 | 21 | 2 | 12668663 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 1693626 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 11071623 | ||
| Pubmed | ADAP is required for normal alphaIIbbeta3 activation by VWF/GP Ib-IX-V and other agonists. | 2.08e-06 | 4 | 21 | 2 | 17003372 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 8918453 | ||
| Pubmed | 3.47e-06 | 175 | 21 | 4 | 28071719 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 19036705 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 18256319 | ||
| Pubmed | Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo. | 3.47e-06 | 5 | 21 | 2 | 16824188 | |
| Pubmed | 3.55e-06 | 176 | 21 | 4 | 27229929 | ||
| Pubmed | 3.65e-06 | 50 | 21 | 3 | 23658023 | ||
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 19332769 | ||
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 27105433 | ||
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 20063990 | ||
| Pubmed | von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. | 7.28e-06 | 7 | 21 | 2 | 1939645 | |
| Pubmed | 9.70e-06 | 8 | 21 | 2 | 20551517 | ||
| Pubmed | 1.56e-05 | 10 | 21 | 2 | 12082590 | ||
| Pubmed | 2.70e-05 | 13 | 21 | 2 | 36350252 | ||
| Pubmed | Membrane-type MMPs are indispensable for placental labyrinth formation and development. | 3.15e-05 | 14 | 21 | 2 | 20858856 | |
| Pubmed | 3.15e-05 | 14 | 21 | 2 | 16005629 | ||
| Pubmed | 3.15e-05 | 14 | 21 | 2 | 36347239 | ||
| Pubmed | 3.15e-05 | 14 | 21 | 2 | 16581250 | ||
| Pubmed | Role of LTBP4 in alveolarization, angiogenesis, and fibrosis in lungs. | 3.63e-05 | 15 | 21 | 2 | 28684544 | |
| Pubmed | Ontogeny of stromal organizer cells during lymph node development. | 4.15e-05 | 16 | 21 | 2 | 20237296 | |
| Pubmed | Cell-matrix signals specify bone endothelial cells during developmental osteogenesis. | 4.15e-05 | 16 | 21 | 2 | 28218908 | |
| Pubmed | Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. | 4.15e-05 | 16 | 21 | 2 | 21067603 | |
| Pubmed | 4.15e-05 | 16 | 21 | 2 | 26953188 | ||
| Pubmed | 5.28e-05 | 18 | 21 | 2 | 11311202 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 5.28e-05 | 18 | 21 | 2 | 39040056 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 7.23e-05 | 135 | 21 | 3 | 28675934 | |
| Pubmed | 9.12e-05 | 146 | 21 | 3 | 27068509 | ||
| Pubmed | 1.05e-04 | 153 | 21 | 3 | 25037231 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.12e-04 | 26 | 21 | 2 | 34189436 | |
| Pubmed | Osteopotentia regulates osteoblast maturation, bone formation, and skeletal integrity in mice. | 1.21e-04 | 27 | 21 | 2 | 20440000 | |
| Pubmed | 1.36e-04 | 167 | 21 | 3 | 22159717 | ||
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 1.50e-04 | 30 | 21 | 2 | 32882513 | |
| Pubmed | 1.60e-04 | 31 | 21 | 2 | 30305289 | ||
| Pubmed | 1.86e-04 | 186 | 21 | 3 | 20452482 | ||
| Pubmed | 1.86e-04 | 186 | 21 | 3 | 20673868 | ||
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 2.28e-04 | 37 | 21 | 2 | 34323105 | |
| Pubmed | 2.41e-04 | 38 | 21 | 2 | 25572963 | ||
| Pubmed | 2.54e-04 | 39 | 21 | 2 | 30566624 | ||
| Pubmed | Uncontrolled angiogenic precursor expansion causes coronary artery anomalies in mice lacking Pofut1. | 3.85e-04 | 48 | 21 | 2 | 28924218 | |
| Interaction | MOBP interactions | 1.86e-11 | 23 | 20 | 5 | int:MOBP | |
| Interaction | HOXA1 interactions | LAMA5 KRTAP10-9 NELL2 KRTAP10-11 KRTAP10-4 KRTAP10-7 VWF KRTAP10-5 TCF19 | 2.14e-11 | 356 | 20 | 9 | int:HOXA1 |
| Interaction | SPATA3 interactions | 2.35e-11 | 24 | 20 | 5 | int:SPATA3 | |
| Interaction | LCE3B interactions | 7.48e-10 | 46 | 20 | 5 | int:LCE3B | |
| Interaction | ZSCAN26 interactions | 2.71e-09 | 59 | 20 | 5 | int:ZSCAN26 | |
| Interaction | LCE3E interactions | 2.96e-09 | 60 | 20 | 5 | int:LCE3E | |
| Interaction | KRTAP5-2 interactions | 3.50e-09 | 62 | 20 | 5 | int:KRTAP5-2 | |
| Interaction | LCE3C interactions | 5.20e-09 | 67 | 20 | 5 | int:LCE3C | |
| Interaction | LCE1E interactions | 5.61e-09 | 68 | 20 | 5 | int:LCE1E | |
| Interaction | LCE2A interactions | 6.05e-09 | 69 | 20 | 5 | int:LCE2A | |
| Interaction | LCE1D interactions | 6.51e-09 | 70 | 20 | 5 | int:LCE1D | |
| Interaction | RSPO2 interactions | 7.40e-09 | 24 | 20 | 4 | int:RSPO2 | |
| Interaction | LCE3D interactions | 8.06e-09 | 73 | 20 | 5 | int:LCE3D | |
| Interaction | LCE2D interactions | 8.64e-09 | 74 | 20 | 5 | int:LCE2D | |
| Interaction | WT1 interactions | 9.90e-09 | 76 | 20 | 5 | int:WT1 | |
| Interaction | LCE4A interactions | 1.28e-08 | 80 | 20 | 5 | int:LCE4A | |
| Interaction | KRTAP4-4 interactions | 1.37e-08 | 81 | 20 | 5 | int:KRTAP4-4 | |
| Interaction | LCE2B interactions | 1.37e-08 | 81 | 20 | 5 | int:LCE2B | |
| Interaction | LCE1A interactions | 1.65e-08 | 84 | 20 | 5 | int:LCE1A | |
| Interaction | LCE1B interactions | 1.75e-08 | 85 | 20 | 5 | int:LCE1B | |
| Interaction | LCE5A interactions | 2.33e-08 | 90 | 20 | 5 | int:LCE5A | |
| Interaction | KRTAP4-11 interactions | 2.61e-08 | 92 | 20 | 5 | int:KRTAP4-11 | |
| Interaction | LCE1F interactions | 2.61e-08 | 92 | 20 | 5 | int:LCE1F | |
| Interaction | KRTAP5-6 interactions | 2.91e-08 | 94 | 20 | 5 | int:KRTAP5-6 | |
| Interaction | KRTAP9-8 interactions | 3.97e-08 | 100 | 20 | 5 | int:KRTAP9-8 | |
| Interaction | ZNF440 interactions | 6.30e-08 | 40 | 20 | 4 | int:ZNF440 | |
| Interaction | ZNF264 interactions | 6.97e-08 | 41 | 20 | 4 | int:ZNF264 | |
| Interaction | ZNF433 interactions | 9.99e-08 | 10 | 20 | 3 | int:ZNF433 | |
| Interaction | CATSPER1 interactions | 1.27e-07 | 126 | 20 | 5 | int:CATSPER1 | |
| Interaction | ZNF155 interactions | 1.37e-07 | 11 | 20 | 3 | int:ZNF155 | |
| Interaction | KRTAP4-2 interactions | 1.60e-07 | 132 | 20 | 5 | int:KRTAP4-2 | |
| Interaction | GLIDR interactions | 1.83e-07 | 12 | 20 | 3 | int:GLIDR | |
| Interaction | ZNF792 interactions | 3.32e-07 | 60 | 20 | 4 | int:ZNF792 | |
| Interaction | KRTAP10-1 interactions | 3.34e-07 | 153 | 20 | 5 | int:KRTAP10-1 | |
| Interaction | OTX1 interactions | 3.56e-07 | 155 | 20 | 5 | int:OTX1 | |
| Interaction | ZNF625 interactions | 3.77e-07 | 15 | 20 | 3 | int:ZNF625 | |
| Interaction | KRTAP5-4 interactions | 4.05e-07 | 63 | 20 | 4 | int:KRTAP5-4 | |
| Interaction | KRTAP10-5 interactions | 4.17e-07 | 160 | 20 | 5 | int:KRTAP10-5 | |
| Interaction | KRTAP10-11 interactions | 4.31e-07 | 64 | 20 | 4 | int:KRTAP10-11 | |
| Interaction | NPDC1 interactions | 4.59e-07 | 65 | 20 | 4 | int:NPDC1 | |
| Interaction | ZNF32 interactions | 4.64e-07 | 16 | 20 | 3 | int:ZNF32 | |
| Interaction | KRTAP5-11 interactions | 4.89e-07 | 66 | 20 | 4 | int:KRTAP5-11 | |
| Interaction | CRCT1 interactions | 4.89e-07 | 66 | 20 | 4 | int:CRCT1 | |
| Interaction | KRTAP5-3 interactions | 4.89e-07 | 66 | 20 | 4 | int:KRTAP5-3 | |
| Interaction | ZNF696 interactions | 5.51e-07 | 68 | 20 | 4 | int:ZNF696 | |
| Interaction | ZNF578 interactions | 5.63e-07 | 17 | 20 | 3 | int:ZNF578 | |
| Interaction | KRTAP4-5 interactions | 8.64e-07 | 76 | 20 | 4 | int:KRTAP4-5 | |
| Interaction | LCE3A interactions | 8.64e-07 | 76 | 20 | 4 | int:LCE3A | |
| Interaction | SMCP interactions | 1.01e-06 | 79 | 20 | 4 | int:SMCP | |
| Interaction | NKD1 interactions | 1.10e-06 | 21 | 20 | 3 | int:NKD1 | |
| Interaction | KRTAP5-9 interactions | 1.35e-06 | 203 | 20 | 5 | int:KRTAP5-9 | |
| Interaction | SPACA9 interactions | 1.46e-06 | 23 | 20 | 3 | int:SPACA9 | |
| Interaction | LCE2C interactions | 1.56e-06 | 88 | 20 | 4 | int:LCE2C | |
| Interaction | SLC23A1 interactions | 2.14e-06 | 26 | 20 | 3 | int:SLC23A1 | |
| Interaction | NUFIP2 interactions | 2.29e-06 | 417 | 20 | 6 | int:NUFIP2 | |
| Interaction | ZNF439 interactions | 2.41e-06 | 27 | 20 | 3 | int:ZNF439 | |
| Interaction | FAM74A4 interactions | 2.41e-06 | 27 | 20 | 3 | int:FAM74A4 | |
| Interaction | FAM76B interactions | 2.50e-06 | 99 | 20 | 4 | int:FAM76B | |
| Interaction | PRKAB2 interactions | 2.72e-06 | 234 | 20 | 5 | int:PRKAB2 | |
| Interaction | TNP2 interactions | 3.69e-06 | 31 | 20 | 3 | int:TNP2 | |
| Interaction | SPRY1 interactions | 3.95e-06 | 111 | 20 | 4 | int:SPRY1 | |
| Interaction | BCL6B interactions | 4.47e-06 | 33 | 20 | 3 | int:BCL6B | |
| Interaction | ZNF697 interactions | 4.47e-06 | 33 | 20 | 3 | int:ZNF697 | |
| Interaction | SLC6A20 interactions | 4.90e-06 | 34 | 20 | 3 | int:SLC6A20 | |
| Interaction | MT1DP interactions | 5.61e-06 | 4 | 20 | 2 | int:MT1DP | |
| Interaction | ZSCAN21 interactions | 6.95e-06 | 128 | 20 | 4 | int:ZSCAN21 | |
| Interaction | ZNF587 interactions | 8.59e-06 | 135 | 20 | 4 | int:ZNF587 | |
| Interaction | KRTAP9-3 interactions | 9.91e-06 | 140 | 20 | 4 | int:KRTAP9-3 | |
| Interaction | ZNF20 interactions | 1.08e-05 | 44 | 20 | 3 | int:ZNF20 | |
| Interaction | CLK4 interactions | 1.08e-05 | 44 | 20 | 3 | int:CLK4 | |
| Interaction | KRTAP9-2 interactions | 1.27e-05 | 149 | 20 | 4 | int:KRTAP9-2 | |
| Interaction | KIAA0040 interactions | 1.40e-05 | 6 | 20 | 2 | int:KIAA0040 | |
| Interaction | AVPI1 interactions | 1.41e-05 | 48 | 20 | 3 | int:AVPI1 | |
| Interaction | ZNF490 interactions | 1.59e-05 | 50 | 20 | 3 | int:ZNF490 | |
| Interaction | ZBTB24 interactions | 1.64e-05 | 159 | 20 | 4 | int:ZBTB24 | |
| Interaction | KRTAP4-12 interactions | 1.72e-05 | 161 | 20 | 4 | int:KRTAP4-12 | |
| Interaction | CREB5 interactions | 1.85e-05 | 164 | 20 | 4 | int:CREB5 | |
| Interaction | HHEX interactions | 2.01e-05 | 54 | 20 | 3 | int:HHEX | |
| Interaction | MXI1 interactions | 2.12e-05 | 55 | 20 | 3 | int:MXI1 | |
| Interaction | ZFP41 interactions | 2.36e-05 | 57 | 20 | 3 | int:ZFP41 | |
| Interaction | ZNF679 interactions | 2.61e-05 | 8 | 20 | 2 | int:ZNF679 | |
| Interaction | ZNF124 interactions | 2.62e-05 | 59 | 20 | 3 | int:ZNF124 | |
| Interaction | ZNF572 interactions | 2.90e-05 | 61 | 20 | 3 | int:ZNF572 | |
| Interaction | KRTAP12-1 interactions | 3.20e-05 | 63 | 20 | 3 | int:KRTAP12-1 | |
| Interaction | CCDC26 interactions | 4.19e-05 | 10 | 20 | 2 | int:CCDC26 | |
| Interaction | NAXD interactions | 4.58e-05 | 71 | 20 | 3 | int:NAXD | |
| Interaction | ZNF778 interactions | 5.12e-05 | 11 | 20 | 2 | int:ZNF778 | |
| Interaction | POM121L8P interactions | 5.12e-05 | 11 | 20 | 2 | int:POM121L8P | |
| Interaction | LCE1C interactions | 5.83e-05 | 77 | 20 | 3 | int:LCE1C | |
| Interaction | COL1A2 interactions | 6.06e-05 | 78 | 20 | 3 | int:COL1A2 | |
| Interaction | ZNF563 interactions | 6.14e-05 | 12 | 20 | 2 | int:ZNF563 | |
| Interaction | ZNF774 interactions | 6.30e-05 | 79 | 20 | 3 | int:ZNF774 | |
| Interaction | ZNF707 interactions | 6.30e-05 | 79 | 20 | 3 | int:ZNF707 | |
| Interaction | BMP7 interactions | 6.54e-05 | 80 | 20 | 3 | int:BMP7 | |
| Interaction | WT1-AS interactions | 7.25e-05 | 13 | 20 | 2 | int:WT1-AS | |
| Interaction | POU4F2 interactions | 7.30e-05 | 83 | 20 | 3 | int:POU4F2 | |
| Interaction | KRTAP10-9 interactions | 8.31e-05 | 241 | 20 | 4 | int:KRTAP10-9 | |
| Interaction | ZNF844 interactions | 8.45e-05 | 14 | 20 | 2 | int:ZNF844 | |
| Interaction | HPCAL1 interactions | 8.69e-05 | 88 | 20 | 3 | int:HPCAL1 | |
| Interaction | DHX57 interactions | 9.88e-05 | 252 | 20 | 4 | int:DHX57 | |
| Cytoband | 21q22.3 | KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 5.77e-16 | 128 | 21 | 8 | 21q22.3 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 3.56e-12 | 377 | 21 | 8 | chr21q22 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.26e-03 | 473 | 21 | 3 | chr17q21 | |
| GeneFamily | Keratin associated proteins | KRTAP16-1 KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 3.49e-16 | 109 | 18 | 9 | 619 |
| Coexpression | NABA_CORE_MATRISOME | 7.83e-12 | 270 | 19 | 8 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 9.07e-12 | 275 | 19 | 8 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.47e-09 | 191 | 19 | 6 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.05e-09 | 196 | 19 | 6 | M3008 | |
| Coexpression | NABA_MATRISOME | 2.41e-07 | 1008 | 19 | 8 | MM17056 | |
| Coexpression | NABA_MATRISOME | 2.76e-07 | 1026 | 19 | 8 | M5889 | |
| Coexpression | DORSEY_GAB2_TARGETS | 2.14e-04 | 30 | 19 | 2 | M14557 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K27ME3 | 2.14e-04 | 30 | 19 | 2 | MM835 | |
| Coexpression | DELYS_THYROID_CANCER_UP | 2.60e-04 | 445 | 19 | 4 | M3645 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 7.01e-06 | 489 | 13 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | 1.19e-05 | 973 | 13 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | 1.21e-05 | 976 | 13 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 1.26e-05 | 984 | 13 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 1.84e-04 | 967 | 13 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | 1.84e-04 | 967 | 13 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | 1.84e-04 | 967 | 13 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | 1.85e-04 | 968 | 13 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 1.88e-04 | 972 | 13 | 5 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 1.90e-04 | 974 | 13 | 5 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 1.94e-04 | 978 | 13 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.94e-04 | 244 | 13 | 3 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 4.18e-04 | 249 | 13 | 3 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.64e-04 | 276 | 13 | 3 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.05e-04 | 298 | 13 | 3 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 7.89e-04 | 734 | 13 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#3_top-relative-expression-ranked_500 | 8.87e-04 | 73 | 13 | 2 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k3_500 | |
| CoexpressionAtlas | ratio_StemCell-blastocyst_vs_cbCD34_top-relative-expression-ranked_500_k-means-cluster#2 | 8.87e-04 | 73 | 13 | 2 | ratio_SC-blastocyst_vs_cbCD34_500_K2 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | KRTAP16-1 KRTAP10-9 KRTAP10-2 KRTAP10-11 KRTAP10-4 KRTAP10-7 KRTAP10-6 KRTAP10-12 KRTAP10-5 | 8.83e-18 | 146 | 21 | 9 | 522c32103c24fc26836bb5b642083904682d9292 |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor-1|TCGA-Testes / Sample_Type by Project: Shred V9 | 1.11e-05 | 93 | 21 | 3 | 2a44d58ae88c05acb18adc959bc2f7cdcc1ac0b3 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma-2|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.59e-05 | 105 | 21 | 3 | 744be8b4255bef3a973db7e4306e52387852e502 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 140 | 21 | 3 | e442c46979d725ec82f525a001c46d971fcade4d | |
| ToppCell | E17.5-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.62e-05 | 150 | 21 | 3 | 201d5b68e71c6c003285428be96c488e6d526edf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-05 | 156 | 21 | 3 | 1c2920f4356789a9c11d5ea1eaafb18a50b19ed7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-05 | 156 | 21 | 3 | 0695ac0f02d059ecf813d61d3c9d4c76d1d85834 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-05 | 156 | 21 | 3 | a45fbe02cd03bd4a097f21368bc1179779ba0db8 | |
| ToppCell | Influenza_Severe-CD4+_Tcm|World / Disease group and Cell class | 5.29e-05 | 157 | 21 | 3 | 842ac087d3d51dba3a6b6937733b73a81aa15e1b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Cajal-Retzius|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.92e-05 | 163 | 21 | 3 | c1484e4de8b10e2f5fb14a7c02b2a015ffe0305e | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.25e-05 | 166 | 21 | 3 | f4698fd08965936d51695d571bd10fb77330d916 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.47e-05 | 168 | 21 | 3 | 9d6ca10c272aea28082c09d469940f7232f6461c | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 170 | 21 | 3 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | Influenza_Severe-CD4+_Tcm|Influenza_Severe / Disease group and Cell class | 6.94e-05 | 172 | 21 | 3 | 47865a04968ca28c6ff125159d9a23e37c8b8af1 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.18e-05 | 174 | 21 | 3 | 99d7421ad5eafe7751ef90698a92f683aa33bca8 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-05 | 180 | 21 | 3 | 9c47852c0a723e2f5cd6898afff4c31a0da06905 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-05 | 180 | 21 | 3 | 499d5fe71e0dc20cffdf85e3b3f14eb4e83e3a3d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-05 | 180 | 21 | 3 | 2405aa5699a8d8cf4c6b3dca07510e774728ac50 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.61e-05 | 185 | 21 | 3 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | severe_influenza-CD4+_Tcm|severe_influenza / disease group, cell group and cell class (v2) | 9.03e-05 | 188 | 21 | 3 | 633e5545f49b1b864b0ffa5fc9688d270690f884 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 194 | 21 | 3 | 04ecb609d233a4b12e275c604810937830363e17 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 194 | 21 | 3 | 775600880bb77781de48085d8744c1030223de1f | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.01e-04 | 195 | 21 | 3 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | -Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-04 | 195 | 21 | 3 | e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.05e-04 | 198 | 21 | 3 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_Tcm|Influenza_Severe / Disease, condition lineage and cell class | 1.05e-04 | 198 | 21 | 3 | fc99f2e300d76126d05c0c43e11cdbbeb74f6f0d | |
| ToppCell | (4)_Endothelial_cells-(4)_Blood_vessel|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.07e-04 | 199 | 21 | 3 | e24d70e79f25cdd3300bf5e2322713355264d4c5 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 199 | 21 | 3 | edba1833ef5c4ca122d7c32f97670314e005f93b | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_Tem|Int-URO / Disease, condition lineage and cell class | 1.07e-04 | 199 | 21 | 3 | c55634d4b66ab4e3f9262a83d993ea0c5f01ea61 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD8+_Tcm|Leuk-UTI / Disease, condition lineage and cell class | 1.07e-04 | 199 | 21 | 3 | 6a1d84f61e1efaab541910926d6911122372659f | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocye.Tnr.Cspg5_(Cspg5)|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.92e-04 | 70 | 21 | 2 | c6d3f8cd3f79e2beb826b07a6b9f3ab35d4f23ea | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocye.Tnr.Cspg5_(Cspg5)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.92e-04 | 70 | 21 | 2 | 823921f8bf585d45f24f627b2b77b228898eb85a | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3-Tnr|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.92e-04 | 70 | 21 | 2 | d2be16550c572ba77261c978648e61dba3eab6bd | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.92e-04 | 70 | 21 | 2 | 52bde49a05f2387fe3e4357422e155bee2e86ae6 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Vwf)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.49e-04 | 74 | 21 | 2 | 0288a3f4eafbc359d01cde4ba58f946dd07c77cb | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.49e-04 | 74 | 21 | 2 | 57884ade66fe39398351685189df5efd7aea0aab | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Vwf)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.49e-04 | 74 | 21 | 2 | 13093139a75bfe11f6b032c9fb402efcc703551c | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Vwf)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.49e-04 | 74 | 21 | 2 | 7f7de9e8142d2435391ee965cee5628e412f0705 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Otx2-Inhibitory_Neuron.Gad1Gad2.Otx2-Chrna3_(SN/VTA_(dorsal_SNr))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.64e-04 | 75 | 21 | 2 | 730a08f846a155d2c892259f2c610081d40fc2c8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Otx2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.64e-04 | 75 | 21 | 2 | f0185de0ce497997df1027a51c099d91294bba07 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Otx2-Inhibitory_Neuron.Gad1Gad2.Otx2-Chrna3_(SN/VTA_(dorsal_SNr))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.64e-04 | 75 | 21 | 2 | 59fe56388697037b335f334cb3461f15c7b3b506 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.90e-04 | 83 | 21 | 2 | 3aa95bf2d8ac37e648037faf3d54ebb243a4fde1 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.90e-04 | 83 | 21 | 2 | 70804dd63221dd5ed26068ec1b50f11875abbc50 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.90e-04 | 83 | 21 | 2 | c1818411438f53aec76afead5c8caab701b95d39 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.90e-04 | 83 | 21 | 2 | 1e7af8aaa20b4c2a77cf2f330113db0faa9d483c | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.58e-04 | 87 | 21 | 2 | cc89f4176b70d4eb5b5bf0ff2319b5f1f9e292c0 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.58e-04 | 87 | 21 | 2 | 4274e04fa4aca85c2cefd8c5e03d0fa4a4f15536 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.58e-04 | 87 | 21 | 2 | 54cbdf80aae3595eaace20c7cbac763282558213 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.58e-04 | 87 | 21 | 2 | 8b1a0bd5d6af32afaca19e9c69f86530bbaa309d | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.47e-04 | 92 | 21 | 2 | ed282f0f3da1593bdec5a2b20af5b8f058574167 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.47e-04 | 92 | 21 | 2 | c5f30d58f235f7a72dfe63f58999c4680502576f | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.47e-04 | 92 | 21 | 2 | 27072dbf6819dca41e41267dc250abfaaf175b2f | |
| ToppCell | TCGA-Prostate-Solid_Tissue_Normal-Prostate_normal_tissue-Prostate_normal_tissue-1|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.10e-03 | 105 | 21 | 2 | 2ea7cd2b5f0728e255aebd573028b0a1dc4410d2 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-03 | 108 | 21 | 2 | d620f07243c2628494e689bbfabc14c453f4b1f4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-03 | 110 | 21 | 2 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-hematologic-erythrocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.58e-03 | 126 | 21 | 2 | cd02f3d4a3fadd24f3a298639b392f0354d227d2 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-03 | 126 | 21 | 2 | c3261ea8726400de87f1c8a5a5134ba2b2884f66 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-hematologic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.58e-03 | 126 | 21 | 2 | f2ec5aa6c649ae1ff99519f6897cf207dc292edf | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Tfh|GI_small-bowel / Manually curated celltypes from each tissue | 1.58e-03 | 126 | 21 | 2 | d0d3e25e4fb074a76313fc90d8c3828b1d8ea486 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-hematologic-erythrocytic-erythrocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.58e-03 | 126 | 21 | 2 | 61a7e400cbc81691b21cd3c37376c1d19fec2270 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.70e-03 | 131 | 21 | 2 | d5bc40cd585582856881081b7130dec3515b4ae0 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-03 | 139 | 21 | 2 | 2fb51abb3ce88c21726c026d6365b2582e2e79f6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.00e-03 | 142 | 21 | 2 | 199a0a1024b6cc446f5ca1f277846a2bdb227a9f | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-03 | 143 | 21 | 2 | e8fc6540a48086f58bc3f42dabe392ef46715b9e | |
| ToppCell | TCGA-Brain-Recurrent_Tumor|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.02e-03 | 143 | 21 | 2 | eeb8ce6e051e18b82b74aaf2fc23f0cb87fc96d5 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-03 | 143 | 21 | 2 | d877d914e4e74db2053baa310d318d6440e672bc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-03 | 147 | 21 | 2 | c8e5bdc3538089acd35a4b41390afaec0ac6d1aa | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD8_Naive|ICU-SEP / Disease, Lineage and Cell Type | 2.20e-03 | 149 | 21 | 2 | a66f3ebf6214b269b137ddd5f4d8d7fb3ef2d962 | |
| ToppCell | COVID-19_Severe-CD8+_T_naive|COVID-19_Severe / disease group, cell group and cell class | 2.28e-03 | 152 | 21 | 2 | e6dbf20504c4fb73d1084b587e040855335b8959 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD8_Naive|Int-URO / Disease, Lineage and Cell Type | 2.28e-03 | 152 | 21 | 2 | 52d6f9cf1f4637c922f582705d625b4cbe3dc0c2 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.31e-03 | 153 | 21 | 2 | 151c469b26f9adf04dd6f117f03bef760cc3d45d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.34e-03 | 154 | 21 | 2 | 89c9c9918af32f3952790b41f1471b2c80ffce2f | |
| ToppCell | normal_Lung-Endothelial_cells-Tumor_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.34e-03 | 154 | 21 | 2 | afdc385397c7b13c9348eeef95f109f2363057ae | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 2.37e-03 | 155 | 21 | 2 | b0e456c4915076e1d38282e116a6eb3230ae80dc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.40e-03 | 156 | 21 | 2 | 7569cab30caafcb273e8ef0b73c9e1bf87076984 | |
| ToppCell | severe_COVID-19-CD8+_T_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.40e-03 | 156 | 21 | 2 | 47aa46cdf5af9834f4b890ac6ce5e8d548ee98db | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD4_TEM|Bac-SEP / Disease, Lineage and Cell Type | 2.40e-03 | 156 | 21 | 2 | ef6bad99bcb30956863cd490c613e251f3b27ba0 | |
| ToppCell | metastatic_Brain-T/NK_cells-Naive_CD8+_T|metastatic_Brain / Location, Cell class and cell subclass | 2.40e-03 | 156 | 21 | 2 | 1dcb0b2d1c4b524e692d40e8403dbf7140af19b4 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|Influenza_Severe / Disease group and Cell class | 2.43e-03 | 157 | 21 | 2 | 287bdc4e455cd0160261a93d13538e0def49fcd4 | |
| ToppCell | severe_influenza-CD4+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 2.46e-03 | 158 | 21 | 2 | ff3fa4bd06e01363429aec4bb587b95819bf0fc9 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.49e-03 | 159 | 21 | 2 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.49e-03 | 159 | 21 | 2 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | severe_influenza-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 2.52e-03 | 160 | 21 | 2 | a1181ef36b453eba53b04d836aa9f65a71354cdb | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.52e-03 | 160 | 21 | 2 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.52e-03 | 160 | 21 | 2 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-2_VIP_PPAPDC1A|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-03 | 160 | 21 | 2 | 7619c31815e41a42864b34ca825c96a2487a5da9 | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_TEM|URO / Disease, Lineage and Cell Type | 2.52e-03 | 160 | 21 | 2 | e406f77b1c1a01d74f39ba65f99d5f8c7d75faf1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-03 | 160 | 21 | 2 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-03 | 161 | 21 | 2 | f4f5d6eaa32169de699c8ff8e8ae35179c8e25c0 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-03 | 161 | 21 | 2 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-03 | 161 | 21 | 2 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | Influenza_Severe-gd_T|World / Disease group and Cell class | 2.56e-03 | 161 | 21 | 2 | b3cdaed4d58d57e3c5dbc904a09388f3bf949407 | |
| ToppCell | COVID-CD8-CD8_2|COVID / Condition, Cell_class and T cell subcluster | 2.56e-03 | 161 | 21 | 2 | 307dcc17475413cd9eb70c27bc447f938ee5723d | |
| ToppCell | Healthy/Control-Treg|World / Disease group and Cell class | 2.56e-03 | 161 | 21 | 2 | 457297cda5c9cee3bcc069fdecbbe24def027e5f | |
| ToppCell | severe_influenza-CD8+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 2.56e-03 | 161 | 21 | 2 | 82196139cdbbd70a36957a87bc9ac6d02575da3f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.56e-03 | 161 | 21 | 2 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-03 | 162 | 21 | 2 | 3f264263878af630921911c2b344ac56eb1e7099 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.59e-03 | 162 | 21 | 2 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | severe_influenza-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 2.59e-03 | 162 | 21 | 2 | 7137990e6e1473665911e39a22092a05ae25ce74 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.59e-03 | 162 | 21 | 2 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| Computational | Adhesion molecules. | 1.18e-04 | 141 | 8 | 3 | MODULE_122 | |
| Computational | Blood coagulation factors. | 2.53e-04 | 33 | 8 | 2 | MODULE_131 | |
| Computational | Bone remodeling. | 6.80e-04 | 54 | 8 | 2 | MODULE_234 | |
| Drug | GRGDTP | 3.24e-08 | 8 | 20 | 3 | CID004644096 | |
| Drug | Grgds | 7.61e-07 | 83 | 20 | 4 | CID000123811 | |
| Drug | Grgdspk | 7.63e-07 | 21 | 20 | 3 | CID000130667 | |
| Drug | Rgds Peptide | 2.03e-06 | 106 | 20 | 4 | CID000107775 | |
| Drug | Gdrgdsp | 2.27e-06 | 109 | 20 | 4 | CID000115346 | |
| Drug | Grgesp | 6.51e-06 | 42 | 20 | 3 | CID000492974 | |
| Drug | Xamoterol hemifumarate [73210-73-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 2.27e-05 | 195 | 20 | 4 | 3401_UP | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.46e-05 | 199 | 20 | 4 | 2235_UP | |
| Drug | Rgd Peptide | 5.03e-05 | 239 | 20 | 4 | CID000104802 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 5.09e-05 | 83 | 20 | 3 | CID011968896 | |
| Drug | Rgdf peptide | 6.63e-05 | 14 | 20 | 2 | CID003080994 | |
| Drug | lotrafiban | 6.63e-05 | 14 | 20 | 2 | CID000080274 | |
| Drug | ticlopidine | 9.69e-05 | 103 | 20 | 3 | CID000005472 | |
| Drug | PPACK | 1.28e-04 | 113 | 20 | 3 | CID003036757 | |
| Drug | ALT-711 | 1.52e-04 | 21 | 20 | 2 | CID000216304 | |
| Drug | MOMC | 1.68e-04 | 22 | 20 | 2 | CID000128338 | |
| Disease | ureidopropionic acid measurement | 2.14e-05 | 16 | 13 | 2 | EFO_0010542 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 4.51e-05 | 23 | 13 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | Nephrotic Syndrome | 6.25e-05 | 27 | 13 | 2 | C0027726 | |
| Disease | factor XI measurement, venous thromboembolism | 7.74e-05 | 30 | 13 | 2 | EFO_0004286, EFO_0004694 | |
| Disease | factor VIII measurement, venous thromboembolism | 9.97e-05 | 34 | 13 | 2 | EFO_0004286, EFO_0004630 | |
| Disease | end stage renal disease (is_implicated_in) | 1.46e-04 | 41 | 13 | 2 | DOID:783 (is_implicated_in) | |
| Disease | end stage renal disease (is_marker_for) | 1.83e-04 | 46 | 13 | 2 | DOID:783 (is_marker_for) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 2.17e-04 | 50 | 13 | 2 | DOID:3770 (biomarker_via_orthology) | |
| Disease | systemic scleroderma (is_marker_for) | 2.44e-04 | 53 | 13 | 2 | DOID:418 (is_marker_for) | |
| Disease | diabetic retinopathy (is_marker_for) | 2.53e-04 | 54 | 13 | 2 | DOID:8947 (is_marker_for) | |
| Disease | venous thromboembolism, fibrinogen measurement | 3.90e-04 | 67 | 13 | 2 | EFO_0004286, EFO_0004623 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CCPGSPVAQTESPCD | 341 | Q12802 | |
| LPENECCPRCVTDPC | 746 | Q99435 | |
| SSRDDPSAPCVSCPC | 1901 | O15230 | |
| TRCDCTPCGTEACDP | 2021 | O15230 | |
| GDTCEKCPTCPDACT | 621 | P05106 | |
| DCPESCCELPCGTPS | 21 | P60368 | |
| DCPESCCEPPCCAPS | 31 | P60372 | |
| CVSSPCCQAVCEPSP | 181 | P60372 | |
| DCPESCCEPPCGTAP | 21 | P60370 | |
| CVSSPCCQAACEPSP | 46 | P60370 | |
| CKPVCCVPTCSEDSS | 136 | P60370 | |
| DCPESCCEPPCCAPA | 36 | P60371 | |
| CVSSPCCQAVCEPSP | 181 | P60371 | |
| PVCCVPTCSEDSSSC | 236 | P60371 | |
| DCPESCCEPPCCAPA | 36 | P60409 | |
| CVSSPCCQAVCEPSP | 181 | P60409 | |
| PVCCVPTCSDDSGSC | 236 | P60409 | |
| DCPESCCEPPCCATS | 21 | P60411 | |
| DCPESCCEPPCSAPS | 21 | P60412 | |
| DCPESCCEPPCCAPA | 31 | P60413 | |
| PSCPVSSCAQPLCCD | 61 | A8MUX0 | |
| PLCCDPVICEPSCSV | 71 | A8MUX0 | |
| PVCCEATTCEPSCSV | 91 | A8MUX0 | |
| PVCCEPAICEPSCSV | 151 | A8MUX0 | |
| AVCCDPSPCEPSCSE | 246 | A8MUX0 | |
| CACGDCPDSIPECQE | 2576 | Q6ZRI0 | |
| LNCLESCTPPGECCP | 176 | Q6ZWJ8 | |
| CPGCSLDTCECPDHI | 196 | Q8IUL8 | |
| CCPVCPDGSESPTDQ | 91 | P02452 | |
| PCAAPCCCLPQEETV | 291 | Q9Y242 | |
| IPGTCCDTCEEPECN | 2711 | P04275 | |
| CEGPCPCPTEQAATS | 176 | Q92563 | |
| VCACPDEPDSRPCSL | 1636 | O75096 |